肺超声严重程度指数:疑似SARS-CoV-2肺炎患者的开发与实用性——一项前瞻性研究
COVID-19患者肺超声严重程度指数更高(16.14 vs 10.08,p<0.001),该指数区分COVID-19的AUROC为0.72(95%CI 0.64-0.78),预测院内死亡的AUROC在全体人群为0.81(95%CI 0.74-0.86)、在COVID-19患者中为0.76(95%CI 0.66-0.84)。
要点
- 肺超声严重程度指数有助于在高验前概率人群中辅助诊断COVID-19肺炎。
- 该指数可预测疑似COVID-19患者的院内死亡风险,COVID-19患者中同样有效。
- COVID-19患者肺超声严重程度指数显著高于非COVID-19患者。
局限性
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Coronavirus disease 2019 (COVID-19) has spread across the world with a strong impact on populations and health systems. Lung ultrasound is increasingly employed in clinical practice but a standard approach and data on the accuracy of lung ultrasound are still needed. Our study's objective was to evaluate lung ultrasound diagnostic and prognostic characteristics in patients with suspected COVID-19. We conducted a monocentric, prospective, observational study. Patients with respiratory distress and suspected COVID-19 consecutively admitted to the Emergency Medicine Unit were enrolled. Lung ultrasound examinations were performed blindly to clinical data. Outcomes were diagnosis of COVID-19 pneumonia and in-hospital mortality. One hundred fifty-nine patients were included in our study; 66% were males and 63.5% had a final diagnosis of COVID-19. COVID-19 patients had a higher mortality rate (18.8% vs. 6.9%, p = 0.04) and Lung Ultrasound Severity Index (16.14 [8.71] vs. 10.08 [8.92], p < 0.001) compared with non-COVID-19 patients. This model proved able to distinguish between positive and negative cases with an area under the receiver operating characteristic (AUROC) equal to 0.72 (95% confidence interval [CI]: 0.64-0.78) and to predict in-hospital mortality with an AUROC equal to 0.81 (95% CI: 0.74-0.86) in the whole population and an AUROC equal to 0.76 (95% CI: 0.66-0.84) in COVID-19 patients. The Lung Ultrasound Severity Index can be a useful tool in diagnosing COVID-19 in patients with a high pretest probability of having the disease and to identify, among them, those with a worse prognosis.
引用
- Spampinato MD, Sposato A, Migliano MT, et al. Lung Ultrasound Severity Index: Development and Usefulness in Patients with Suspected SARS-Cov-2 Pneumonia-A Prospective Study. Ultrasound Med Biol. 2021. PMID: 34548188. doi:10.1016/j.ultrasmedbio.2021.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。